BRPI0513622A - aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes - Google Patents

aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes

Info

Publication number
BRPI0513622A
BRPI0513622A BRPI0513622-9A BRPI0513622A BRPI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A
Authority
BR
Brazil
Prior art keywords
surfactants
seeds
self
lipid excipients
emulsifying
Prior art date
Application number
BRPI0513622-9A
Other languages
English (en)
Inventor
Jean Pachot
Serge Segot Chicq
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0513622A publication Critical patent/BRPI0513622A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

APLICAçãO DE COMBINAçõES AUTO-EMULSIFICANTES (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES; COMPOSIçãO FARMACêUTICA CONTENDO UM PRINCìPIO ATIVO E UMA COMBINAçãO AUTO-EMULSIFICANTE (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES; E PROCESSO PARA A PREPARAçãO DE COMBINAçõES AUTO-EMULSIFICANTES (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES, onde as formulações farmacêuticas inovadoras tornam possível melhorar a absorção intestinal de princípios ativos administrados oralmente, seu processo de preparação e a aplicação de excipientes lipídicos em combinação com um ou mais surfactantes e um ou mais co-surfactantes para a inibição de bombas de refluxo.
BRPI0513622-9A 2004-07-27 2005-07-20 aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes BRPI0513622A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408269A FR2873585B1 (fr) 2004-07-27 2004-07-27 Nouvelles formulations galeniques de principes actifs
PCT/FR2005/001853 WO2006018501A1 (fr) 2004-07-27 2005-07-20 Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques

Publications (1)

Publication Number Publication Date
BRPI0513622A true BRPI0513622A (pt) 2008-05-13

Family

ID=34951660

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513622-9A BRPI0513622A (pt) 2004-07-27 2005-07-20 aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes

Country Status (18)

Country Link
US (2) US20080193519A1 (pt)
EP (1) EP1771154A1 (pt)
JP (1) JP2008508191A (pt)
KR (1) KR20070046819A (pt)
CN (1) CN101001608A (pt)
AU (1) AU2005273839A1 (pt)
BR (1) BRPI0513622A (pt)
CA (1) CA2579449A1 (pt)
FR (1) FR2873585B1 (pt)
IL (1) IL180714A0 (pt)
MA (1) MA28748B1 (pt)
MX (1) MX2007001141A (pt)
NO (1) NO20070354L (pt)
NZ (1) NZ552715A (pt)
RU (1) RU2381789C2 (pt)
TW (1) TW200616640A (pt)
WO (1) WO2006018501A1 (pt)
ZA (1) ZA200700553B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
AU2008290536B2 (en) * 2007-08-21 2012-02-09 Basilea Pharmaceutica Ag Antifungal composition
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
JP2013209294A (ja) * 2010-07-30 2013-10-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 液状医薬組成物
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20210102936A (ko) * 2018-12-10 2021-08-20 헤일로 사이언스 엘엘씨 안정적인 마취제 제제 및 관련 복용량 형태
CZ309587B6 (cs) * 2021-01-22 2023-05-03 Oncora S.R.O. Mikroemulzní prekoncentrát s obsahem kladribinu a způsob jeho přípravy
CN114246827B (zh) * 2022-01-04 2023-04-11 中山大学 一种鱼油微乳制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
EP0933367A1 (en) * 1997-12-19 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
SK10632000A3 (sk) * 1998-01-23 2001-02-12 Aventis Pharma Deutschland Gmbh Sulfónamidové deriváty ako inhibítory resorpcie kostí a inhibítory bunkovej adhézie
ATE327735T1 (de) * 1998-04-01 2006-06-15 Jagotec Ag Taxan-mikroemulsionen
WO2000003753A2 (en) * 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
GB0003685D0 (en) * 2000-02-17 2000-04-05 Univ Cardiff Sensitisation of cellular material
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
FR2827770B1 (fr) * 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
WO2003095447A1 (en) * 2002-05-14 2003-11-20 Xenova Limited Process for the preparation of a hydrate of an anthranilic acid derivative

Also Published As

Publication number Publication date
MA28748B1 (fr) 2007-07-02
US20110104268A1 (en) 2011-05-05
WO2006018501A8 (fr) 2007-03-01
KR20070046819A (ko) 2007-05-03
NO20070354L (no) 2007-04-17
CA2579449A1 (en) 2006-02-23
FR2873585A1 (fr) 2006-02-03
TW200616640A (en) 2006-06-01
ZA200700553B (en) 2008-05-28
IL180714A0 (en) 2007-06-03
US20080193519A1 (en) 2008-08-14
AU2005273839A1 (en) 2006-02-23
MX2007001141A (es) 2007-04-19
NZ552715A (en) 2010-12-24
RU2381789C2 (ru) 2010-02-20
CN101001608A (zh) 2007-07-18
FR2873585B1 (fr) 2006-11-17
EP1771154A1 (fr) 2007-04-11
RU2007107199A (ru) 2008-09-10
WO2006018501A1 (fr) 2006-02-23
JP2008508191A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
BRPI0513622A (pt) aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
BRPI0519280A2 (pt) composto, composiÇço farmacÊutica e uso de um composto
NO20082269L (no) Nye piperaziner som antimalariamidler
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
MY143549A (en) Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
FR2878161B1 (fr) Forme medicamenteuse orale, solide et concue pour eviter le mesusage
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
ECSP067074A (es) Derivados de 4-fenil-pirimidina-2-carbonitrilo
BRPI0614197B8 (pt) composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina
AR053333A1 (es) Composiciones farmaceuticas orales y parenterales que contienen altas concentraciones de agentes solubilizantes aromaticos
EA200602199A1 (ru) Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство
PT1208078E (pt) Sais nao higroscopicos de substancias activas com actividades terapeuticas e/ou nutricionais e composicoes passiveis de serem administradas oralmente contendo os mesmos
BR0215352A (pt) Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.